The objective is to describe the outcomes of patients with human immunodeficiency virus (HIV) infection who received extracorporeal membrane oxygenation (ECMO) for severe respiratory failure (SRF). The design and setting was a single centre retrospective observational case series, from January 2012 to June 2017, at a tertiary university hospital and regional referral centre for ECMO in the United Kingdom. The participants were all patients referred with SRF and HIV infection. The main outcome measure was patient 90-day survival. Twenty-four patients were referred, of whom nine received ECMO. Six out of nine (67%) of patients were alive at 90 days. Median duration of ECMO was 18 days. There were no identified differences between survivors and non-survivors. ECMO can be used successfully in selected patients with HIV and SRF, including those with poor HIV control and high illness severity. HIV status alone should not exclude patients from treatment with extracorporeal therapy.
RodgerAJLodwickRSchechterMet al.
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS2013;
27: 973–979.
2.
NakagawaFMayMPhillipsA.Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis2013;
26: 17–25.
3.
SarkarPRasheedHF.Clinical review: respiratory failure in HIV-infected patients – a changing picture. Crit Care2013;
17: 228.
4.
MillerRFAllenECopasAet al.
Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax2006;
61: 716–721.
5.
AkgunKMPisaniMCrothersK.The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med2011;
26: 151–164.
6.
CoquetIPavieJPalmerPet al.
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care2010;
14: R107.
7.
BarbierFCoquetILegrielSet al.
Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med2009;
35: 1678–1686.
8.
DicksonSJBatsonSCopasAJet al.
Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax2007;
62: 964–968.
9.
HuangLQuartinAJonesDet al.
Intensive care of patients with HIV infection. N Engl J Med2006;
355: 173–181.
10.
PowellKDavisJLMorrisAMet al.
Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest2009;
135: 11–17.
11.
Mendez-TellezPADamlujiAAmmermanDet al.
Human immunodeficiency virus infection and hospital mortality in acute lung injury patients. Crit Care Med2010;
38: 1530–1535.
12.
NirappilFJMaheshwariAAndrewsJet al.
Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome. J Crit Care2015;
30: 60–64.
13.
MasurH.Management of patients with HIV in the intensive care unit. Proc Am Thorac Soc2006;
3: 96–102.
14.
CurtisJRYarnoldPRSchwartzDNet al.
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med2000;
162: 393–398.
15.
De PaloVAMillsteinBHMayoPHet al.
Outcome of intensive care in patients with HIV infection. Chest1995;
107: 506–510.
16.
MosierJMKelseyMRazYet al.
Extracorporeal membrane oxygenation (ECMO) for critically ill adults in the emergency department: history, current applications, and future directions. Crit Care2015;
19: 431.
17.
PeekGJMugfordMTiruvoipatiRet al.
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet2009;
374: 1351–1363.
18.
PadenMLConradSARycusPTet al.
Extracorporeal life support organization registry report 2012. ASAIO J2013;
59: 202–210.
19.
BarrettNCamporotaLLangrishCet al.
Individualising management of severe respiratory failure and the specialist commissioned severe respiratory failure service for England. J Intensive Care Soc2013;
14: 114–119.
20.
GutermannHvan RoyBMeerssemanWet al.
Successful extracorporeal lung assistance for overwhelming pneumonia in a patient with undiagnosed full blown aids – a controversial therapy in HIV-patients. Thorac Cardiovasc Surg2005;
53: 252–254.
21.
Extracorporeal Life Support Organization. ELSO Adult Respiratory Failure Supplement to the ELSO General Guidelines, Version 1.3, December 2013.
22.
NSW Health. Critical care tertiary networks & transfer of care (Adults) PD2010_021, www.health.nsw.gov.au/pds (2010, accessed 1 October 2017).
NHS Commissioning Board. NHS standard contract for extracorporeal membrane oxygenation for adults with respiratory failure D16/S(HSS)/a, 2013, www.england.nhs.uk (accessed 6 June 2017)
25.
MurrayJFMatthayMALuceJMet al.
An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis1988;
138: 720–723.
26.
BurnsJCooperESaltGet al.
Retrospective observational review of percutaneous cannulation for extracorporeal membrane oxygenation. ASAIO J2016;
62: 325–328.
27.
SherrenPBShepherdSJGloverGWet al.
Capabilities of a mobile extracorporeal membrane oxygenation service for severe respiratory failure delivered by intensive care specialists. Anaesthesia2015;
70: 707–714.
28.
Selik RM, Mokotoff ED, Branson B, et al. Revised surveillance case definition for HIV infection–United States, 2014.MMWR Recomm Rep2014; 63: 1–10.
29.
SchmidtMZogheibERozeHet al.
The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med2013;
39: 1704–1713.
30.
SchmidtMBaileyMSheldrakeJet al.
Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med2014;
189: 1374–1382.
31.
De RosaFGFanelliVCorcioneSet al.
Extra corporeal membrane oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome. BMC Anesthesiol2014;
14: 37.
32.
CawcuttKGallo De MoraesALeeSJet al.
The use of ECMO in HIV/AIDS with Pneumocystis jirovecii pneumonia: a case report and review of the literature. ASAIO J2014;
60: 606–608.
33.
AliHSHassanIFGeorgeS.Extra corporeal membrane oxygenation to facilitate lung protective ventilation and prevent ventilator-induced lung injury in severe Pneumocystis pneumonia with pneumomediastinum: a case report and short literature review. BMC Pulm Med2016;
16: 52.
34.
SamalaviciusRSerpytisMRingaitieneDet al.
Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome. AIDS Res Ther2014;
11: 37.
35.
HorikitaSSanuiMFujimotoYet al. Successful repeat ECMO in a patient with AIDS and ARDS. BMJ Case Rep. Epub ahead of print 20 September 2017. DOI: 10.1136/bcr-2017-219870.
36.
FrickSEFlothmannCPreiswerkBet al.
Extracorporeal membrane oxygenation in miliary tuberculosis and AIDS: a case report. Thorac Cardiovasc Surg Rep2015;
4: 18–20.
37.
MorleyDLynamACartonEet al.
Extracorporeal membrane oxygenation in an HIV-positive man with severe acute respiratory distress syndrome secondary to pneumocystis and cytomegalovirus pneumonia. Int J STD AIDS2018;
29: 198–202.
38.
CapatosGBurkeCROginoMTet al. Venovenous extracorporeal life support in patients with HIV infection and Pneumocystis jirovecii pneumonia. Perfusion 2018; 33: 433–437.
39.
SchmidtMSchellongowskiPPatronitiNet al. Six-month outcome of immunocompromised severe ARDS patients rescued by ECMO. An international multicenter retrospective study. Am J Respir Crit Care Med 2018; 197: 1297–1307.
40.
MorquinDLe MoingVMuraTet al.
Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care2012;
2: 25.
41.
CrodaJCrodaMGNevesAet al.
Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med2009;
37: 1605–1611.
42.
MeybeckALecomteLValetteMet al.
Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study. AIDS Res Ther2012;
9: 27.
